Technoderma Medicines Completes Positive Ph2a Proof- of Concept Trial with Topical TDM-180935 Ointment for Atopic Dermatitis
CHENGDU, China, Jan. 6, 2025 /PRNewswire/ -- Technoderma Medicines, Inc. ("the Company"), a clinical stage biopharmaceutical company, is pleased to report the Company has completed its Phase 2a clinical trial (NCT06363461) of topical TDM-180935...
Beatbot to Introduce the Amphibious RoboTurtle and Shore Self-Docking & Charging Station at CES 2025
Two Game-Changing Innovations in Smart Pool Care and Environmental Stewardship LAS VEGAS, Jan. 6, 2025 /PRNewswire/ -- Beatbot, the brand behind the world's most innovative robotic pool cleaners, unveiled two transformative innovations designed to...
NTQ Unveils Brand Transformation and Kickstarts the Global IT Service Provider Vision
HANOI, Vietnam, Jan. 6, 2025 /PRNewswire/ -- On January 6, NTQ (formerly known as NTQ Solution), a trusted name in IT services and technology solutions, officially unveiled its transformative rebranding strategy after nearly 14 years of success....
Concord Medical Announces Result of 2024 Annual General Meeting
BEIJING, Jan. 6, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced...
i2Cool Powers Green Event Management at Hong Kong Coliseum with Electricity-free Cooling Technology
HONG KONG, Jan. 6, 2025 /PRNewswire/ -- i2Cool, a trailblazer in passive radiative cooling technology, has successfully applied its green and energy-efficient paint to the rooftop and side walls of the Hong Kong Coliseum. Supported by the...
I-Mab Announces Portfolio Prioritization of Givastomig (CLDN18.2 x 4-1BB Bispecific Antibody) as Lead Clinical Program
Givastomig: a Claudin 18.2 ("CLDN18.2") x 4-1BB bispecific antibody, will be the lead clinical program following the Company's portfolio prioritization The Company has completed enrollment of a dose escalation study of givastomig in combination with...
New Hong Kong Talent Service Association Successfully Hosts "Hong Kong Food and Beverage Industry Investment Forum" with strategic partner InvestHK
Guide: Seizing Investment Opportunities in Hong Kong, Lead the Future of the Food and Beverage Industry HONG KONG, Jan. 6, 2025 /PRNewswire/ -- The New Hong Kong Talent Service Association successfully hosted the highly anticipated "Hong Kong Food...
CHINA NATURAL RESOURCES GRANTED SECOND 180-DAY PERIOD BY NASDAQ TO REGAIN COMPLIANCE WITH MINIMUM BID PRICE RULE
HONG KONG, Jan. 6, 2025 /PRNewswire/ -- China Natural Resources Inc. (NASDAQ: CHNR) (the "Company") today announced that on January 3, 2025, the Company has been granted an additional 180-day period from Nasdaq's Listing Qualifications Department,...